NewslettersMesenchymal Cell NewsUncategorizedAMTB, a TRPM8 Antagonist, Suppresses Growth and Metastasis of Osteosarcoma through Repressing the TGFβ Signaling PathwayBy Justin.choi - March 31, 2022071Investigators found that N-(3-aminopropyl)-2-[(3-methylphenyl) methoxy]-N-(2-thienylmethyl) benzamide hydrochloride (AMTB) suppressed osteosarcoma cell proliferation, metastasis and induced cellular apoptosis.[Cell Death & Disease] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173532 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article